Association Between Alendronate Use and Hip Fracture Risk in Older Patients Using Oral Prednisolone-Reference-Cited by-同舟云学术

Association Between Alendronate Use and Hip Fracture Risk in Older Patients Using Oral Prednisolone

Published:2017-07-11 Issue:2 Volume:318 Page:146
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Axelsson Kristian F.¹,Nilsson Anna G.²,Wedel Hans³,Lundh Dan⁴,Lorentzon Mattias⁵

Affiliation:

1. Department of Orthopaedic Surgery, Skaraborg Hospital, Skövde, Sweden2Geriatric Medicine, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden

2. Geriatric Medicine, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden3Department of Endocrinology, Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden

3. Health Metrics, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

4. School of Bioscience, University of Skövde, Skövde, Sweden

5. Geriatric Medicine, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden6Geriatric Medicine, Sahlgrenska University Hospital, Mölndal, Sweden

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucocorticoid-induced osteoporosis—from molecular mechanism to clinical practice;Drugs & Therapy Perspectives;2024-07-18

2. Bone quality in zebrafish vertebrae improves after alendronate administration in a glucocorticoid-induced osteoporosis model;Journal of the Mechanical Behavior of Biomedical Materials;2024-06

3. A Bone Targeting Nanoparticle Loaded OGP to Restore Bone Homeostasis for Osteoporosis Therapy;Advanced Healthcare Materials;2023-08-18

4. Combined and sequential therapies with anabolic and antiresorptive drugs in the management of patients with postmenopausal osteoporosis;International Journal of Bone Fragility;2023-06-01

5. Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?;Endocrine Reviews;2023-05-30